ACC Latin America 2022 Together with CardioAcademic Focuses on Global Collaboration

The American College of Cardiology and CardioAcademic will host ACC Latin America 2022 Together with CardioAcademic in Mexico City from September 10-11, 2022. The event will bring the Latin American cardiology community together to examine emerging trends and evidence-based strategies for the prevention and management of cardiovascular disease, as well as present exciting new research being done in the region.

ACC Vice President B. Hadley Wilson, MD, FACC, executive vice-chair at the Sanger Heart & Vascular Institute, and ACC Assembly of International Governors Past Chair Erick Alexanderson, MD, FACC, chairman of the Nuclear Cardiology Department at the Instituto Nacional de Cardiología “Ignacio Chávez” and director of CardioAcademic, will serve as co-chairs for the conference.

“ACC‘s vision is a world where science knowledge and innovation optimize cardiovascular care and outcomes and what better way than getting together at ACC Latin America regional conference paired with CardioAcademic in Mexico City,” Wilson said. “These are two great meeting venues joined together for the best Latin America regional conference with cardiovascular thought leaders, along with other leaders in the Americas creating a dynamic exchange of leading-edge knowledge and practical networking. We’re sure attendees will find plenty to take home and put into practice for their patients.”

Valentin Fuster, MD, PhD, MACC, editor-in-chief of the Journal of the American College of Cardiology, will present the Opening Plenary Session, “New Frontiers in Cardiovascular Health: From the Heart to the Brain.” Other key sessions will examine the top cardiovascular complications of COVID-19, beginning primary prevention of heart disease through childhood education and the care of cardio-oncology patients. In addition to in-person sessions, the conference will feature a hybrid option with attendees having access to all virtual content.

Learn more about the conference at ACC.org/LatinAmerica2022.

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.